• About us
  • Contact us
  • Our team
  • Terms of Service
Saturday, November 14, 2026
Kashmir Images - Latest News Update
Epaper
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER
No Result
View All Result
Kashmir Images - Latest News Update
No Result
View All Result
Home Latest News

Drug Cocktail, Proving Effective In Covid-19 Cases, Started In Kashmir

KI News by KI News
June 20, 2021
in Latest News
A A
0
Health Ministry asks AIOCD to ensure availability of critical drugs for management of COVID-19
FacebookTwitterWhatsapp

Srinagar: Doctors here started using a monoclonal antibody cocktail for quick and effective result in controlling the viral load in mild to moderate covid-19 cases.

Experts describe the cocktail of casirivimab and imdevimab, the two monoclonal antibody drugs, as very effective in treating patients diagnosed to be mild or moderate covid-19 cases.

More News

Religious leaders call for simpler weddings, traditional seven-dish Wazwan

IIT entrance exam JEE-Advanced on May 23, 2027

Director Information reviews functioning of DICs in Jammu Division

Load More

Principal GMC Srinagar, Dr Samia Rashid, told GNS that in Kashmir Valley it has been so far started in CD hospital here.

Already ten Covid-19 patients have thus far undergone antibody cocktail treatment at CD hospital, one of the exclusive facilities for the management of the covid-19 patients in Valley, with successful outcomes, Dr Naveed Nazir Shah, who is the head of department at Chest Diseases Hospital, Srinagar, told GNS.

“Actually it’s recommended for mild to moderate covid-19 patients who do not need oxygen,” Dr Naveed said when contacted by GNS.

The cocktail drug used at several places across India is said to be effective in reducing requirement for hospitalisation in about 70 per cent of “eligible” patients.

The patients who were started on the cocktail within seven days of having their first symptoms started fast recovering, the experts said.

The cocktail, the experts underlined works best within three days of symptom onset and is effective up to a week from the onset of symptoms.

“It doesn’t allow progression of the disease,” Naveed, leading pulmonologist said. “That’s why it is given to high risk patients only,” he added.

So far 100 vials have been provided to CD hospital, Dr Naveed confirmed. “It is being provided free of costs by the JKMSCL.”

Managing Director Jammu and Kashmir Medical Supplies Corporation Limited (JKMSCL), Dr Yashpal Sharma, told GNS that 350 vials have been so far distributed for use in Jammu and Kashmir. The drug cocktail costs around Rs 60 thousand.

The “Emergency Use Authorisation” of cocktail drug has been approved by Central Drugs Standards Control Organisation (CDSCO) and is being marketed by the Cipla in India.

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses. They are specifically directed against the spike protein of the novel coronavirus.

The cocktail remains efficacious against widest spread variants and reduces the risk of losing its neutralization potency against new emerging variants, the experts say. (GNS)

Previous Post

37-year-old woman among 8 more die of covid-19 in J&K

Next Post

Delhi—J&K talks: PDP PAC members authorizes Mehbooba to decide on participation

KI News

KI News

Kashmir Images is an English language daily newspaper published from Srinagar (J&K), India. The newspaper is one of the largest circulated English dailies of Kashmir and its hard copies reach every nook and corner of Kashmir Valley besides Jammu and Ladakh region.

Related Posts

Religious leaders call for simpler weddings, traditional seven-dish Wazwan

Jama Masjid Friday congregation condemns Pahalgam massacre
November 14, 2026

Srinagar: With Kashmir's wedding celebrations increasingly turning into "a competition" over food, spending and social status, religious leaders across the...

Read moreDetails

IIT entrance exam JEE-Advanced on May 23, 2027

Examination Controller is not a flying bird
November 14, 2026

NEW DELHI: IIT entrance exam JEE-Advanced will be conducted on May 23, 2027, the Indian Institute of Technology (IIT), Delhi,...

Read moreDetails

Director Information reviews functioning of DICs in Jammu Division

Director Information reviews functioning of DICs in Jammu Division
November 13, 2026

Jammu: Director Information and Public Relations Mamta Yadav on Friday reviewed the functioning of District Information Centres (DICs) across Jammu...

Read moreDetails

Mughal Road reopens; commuters advised caution

Mughal Road reopens for one-way traffic
November 13, 2026

Shopian: The Mughal Road was reopened for vehicular traffic on Friday after the Border Roads Organisation (BRO) cleared snow accumulated...

Read moreDetails

DGP orders major reshuffle of 136 DySPs

Govt orders transfers in administration 
November 13, 2026

Srinagar: The Jammu and Kashmir Police Headquarters has ordered the transfer and posting of 136 Deputy Superintendents of Police (DSPs)...

Read moreDetails

Special DG CRPF meets LG

Special DG CRPF meets LG
November 13, 2026

SRINAGAR: Special Director General, CRPF, Jammu and Kashmir Zone, Sandeep Khirwar, on Thursday called on Lieutenant Governor Manoj Sinha here...

Read moreDetails
Next Post
Mehbooba questions ban on over 30 TV channels

Delhi—J&K talks: PDP PAC members authorizes Mehbooba to decide on participation

  • About us
  • Contact us
  • Our team
  • Terms of Service
E-Mailus: kashmirimages123@gmail.com

© 2025 Kashmir Images - Designed by GITS.

No Result
View All Result
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER

© 2025 Kashmir Images - Designed by GITS.